SynthesisFrontiers in oncology2024

First-line treatment for advanced or metastatic EGFR mutation-positive non-squamous non-small cell lung cancer: a network meta-analysis.

Mengyao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.